Quotes 5-day view Delayed London Stock Exchange
11/27/2020
11/30/2020
12/01/2020
12/02/2020
12/03/2020
Date
2632(c)
2608(c)
2481(c)
2532(c)
2544(c)
Last
601 066
1 909 258
680 485
624 562
401 044
Volume
-0.08% -0.91% -4.87% +2.06% +0.47% Change
Sales 2020
2 326 M - -
Net income 2020
404 M - -
Net Debt 2020
355 M - -
P/E ratio 2020
20,0x
Yield 2020
1,43%
Sales 2021
2 495 M - -
Net income 2021
426 M - -
Net Debt 2021
126 M - -
P/E ratio 2021
18,7x
Yield 2021
1,58%
Capitalization
7 801 M 7 785 M -
EV / Sales 2020
3,51x
EV / Sales 2021
3,18x
Nbr of Employees
8 600
Free-Float
67,6%
Hikma Pharmaceuticals PLC specializes in developing, producing, and selling drugs used in treating cardiovascular diseases, infections, cancers, diabetes, etc. Net sales break down by family of products as follows:
- generic injectable products (40.5%);
- generic products taken orally (32.6%);
- brand name drugs (26.4%);
- other (0.5%).
Net sales are distributed geographically as follows: the United Kingdom...
Notations Surperformance© of Hikma Pharmaceuticals PLC
Trading Rating : Investor Rating :
All news about HIKMA PHARMACEUTICALS PLC
News in other languages on HIKMA PHARMACEUTICALS PLC
11/12 AVIS D'ANALYSTES DU JOUR : Alcon, BMW, Delivery Hero, Getlink, Logitech, Rubis, ..09/22 AVIS D'ANALYSTES DU JOUR : EDF, Hikma, Innate Pharma, Natixis, Rio Tinto, Roche,..09/04 AVIS D'ANALYSTES DU JOUR : Adyen, Amadeus, Capgemini, Casino, Logitech, Michelin..08/10 LONDON STOCK EXCHANGE : Londres portée par les annonces de Trump08/10 LONDON STOCK EXCHANGE : Londres optimiste sur la reprise économique
Analyst Recommendations on HIKMA PHARMACEUTICALS PLC
HIKMA PHARMACEUTICALS PLC - 09/09
Technically solid
BUY
Blues health insurers put up $55 million to take on generic drug makers
Chart HIKMA PHARMACEUTICALS PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends HIKMA PHARMACEUTICALS PLC
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Average target price
34,51 $
Last Close Price
33,85 $
Spread / Highest target
18,3%
Spread / Average Target
1,96%
Spread / Lowest Target
-43,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
